| Research
> Anemia |
| One key area of our research is
Hematocrit
level and its effect on your health. We believe that your
health is benefited when your hematocrit is raised to a level greater than 30% as soon as
possible, and that the longer your hematocrit is kept above 33% the better chance you have
of living a longer life. We have also found that when your hematocrit is kept above 33%
the chance of you being hospitalized decreases, and the length of your stays in the
hospital will most likely be shorter. |
New Therapies for Anemia Management in CKD: An Interactive Symposium on the Full Spectrum of Kidney Disease
American Society of Nephrology, October 2001 |
| View
Presentation - Download |
Early hematocrit correction among incident hemodialysis patients: patterns of erythropoietin dosing & iron therapy
American Society of Nephrology, October 2001 |
| View
Presentation - Download |
Correction of anemia with erythropoietin in the two years pre-ESRD: cardiac disease associated with pre-ESRD EPO
American Society of Nephrology, October 2001 |
| View
Presentation - Download |
Higher hematocrits are associated with lower rates of cardiovascular ischemic events
American Society of Nephrology, October 2001 |
| View
Presentation - Download |
Rates of rise in U.S. hematocrit levels & EPO doses may
be stabilizing.
American Society of Nephrology, October 2000 |
| View
Presentation - Download |
Changing hematocrit levels: Clinical predictors for
hemodialysis patients to move from low (<30%) to higher
(>30%) hematocrits.
American Society of Nephrology, October 2000 |
| View
Presentation - Download |
| |
